Research advances in proton pump inhibitor and complications of liver cirrhosis / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2557-2560, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-829642
ABSTRACT
Proton pump inhibitor (PPI) is often used for the prevention and treatment of digestive system diseases, and the adverse outcomes caused by the use of PPI are increasingly concerned by scholars. This article elaborates on the association of the complications of liver cirrhosis, such as upper gastrointestinal bleeding, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatocellular carcinoma, and infection, and the change in gut microbiota with the use of PPI, and points out that in clinical practice, it is important to master the medication rules of PPI, understand the risk of complications caused by PPI, and actively improve the complications caused by medication.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS